EDGAR Filing Documents for 0001493152-23-027642

Form 8-K - Current report:

SEC Accession No. 0001493152-23-027642

Filing Date

2023-08-10

Accepted

2023-08-10 17:29:01

Documents

Period of Report

2023-08-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	94651
2		ex3-1.htm	EX-3.1	359507
3		ex10-1.htm	EX-10.1	341634
4		ex10-2.htm	EX-10.2	218005
5		ex10-3.htm	EX-10.3	212748
6		ex10-4.htm	EX-10.4	324148
7		ex10-5.htm	EX-10.5	64416
	Complete submission text file	0001493152-23-027642.txt		2136095

Data Files

Seq	Description	Document	Type	Size
8	INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	evfm-20230804.xsd	EX-101.SCH	3009
9	INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	evfm-20230804_lab.xml	EX-101.LAB	34240
10	INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	evfm-20230804_pre.xml	EX-101.PRE	22355
12	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3336

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130

Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900

Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)